Altered quantitative sensory testing outcome in subjects with opioid therapy
- PMID: 19237249
- PMCID: PMC2680088
- DOI: 10.1016/j.pain.2009.01.022
Altered quantitative sensory testing outcome in subjects with opioid therapy
Abstract
Preclinical studies have suggested that opioid exposure may induce a paradoxical decrease in the nociceptive threshold, commonly referred as opioid-induced hyperalgesia (OIH). While OIH may have implications in acute and chronic pain management, its clinical features remain unclear. Using an office-based quantitative sensory testing (QST) method, we compared pain threshold, pain tolerance, and the degree of temporal summation of the second pain in response to thermal stimulation among three groups of subjects: those with neither pain nor opioid therapy (group 1), with chronic pain but without opioid therapy (group 2), and with both chronic pain and opioid therapy (group 3). We also examined the possible correlation between QST responses to thermal stimulation and opioid dose, opioid treatment duration, opioid analgesic type, pain duration, or gender in group 3 subjects. As compared with both group 1 (n=41) and group 2 (n=41) subjects, group 3 subjects (n=58) displayed a decreased heat pain threshold and exacerbated temporal summation of the second pain to thermal stimulation. In contrast, there were no differences in cold or warm sensation among three groups. Among clinical factors, daily opioid dose consistently correlated with the decreased heat pain threshold and exacerbated temporal summation of the second pain in group 3 subjects. These results indicate that decreased heat pain threshold and exacerbated temporal summation of the second pain may be characteristic QST changes in subjects with opioid therapy. The data suggest that QST may be a useful tool in the clinical assessment of OIH.
Conflict of interest statement
The authors claim no conflict of interest.
Figures

Similar articles
-
Increased pain sensitivity in chronic pain subjects on opioid therapy: a cross-sectional study using quantitative sensory testing.Pain Med. 2015 May;16(5):911-22. doi: 10.1111/pme.12606. Epub 2014 Nov 6. Pain Med. 2015. PMID: 25376890
-
Chronic Opioid Therapy Modifies QST Changes After Ketamine Infusion in Chronic Pain Patients.J Pain. 2017 Dec;18(12):1468-1475. doi: 10.1016/j.jpain.2017.07.008. Epub 2017 Aug 10. J Pain. 2017. PMID: 28802882 Free PMC article. Clinical Trial.
-
Sensory determinants of thermal pain.Brain. 2002 Mar;125(Pt 3):501-10. doi: 10.1093/brain/awf055. Brain. 2002. PMID: 11872608
-
Opioid-Induced Hyperalgesia in the Nonsurgical Setting: A Systematic Review.Am J Ther. 2019 May/Jun;26(3):e397-e405. doi: 10.1097/MJT.0000000000000734. Am J Ther. 2019. PMID: 29726847
-
Evidence of opioid-induced hyperalgesia in clinical populations after chronic opioid exposure: a systematic review and meta-analysis.Br J Anaesth. 2019 Jun;122(6):e114-e126. doi: 10.1016/j.bja.2018.09.019. Epub 2018 Oct 25. Br J Anaesth. 2019. PMID: 30915985
Cited by
-
Gi-protein-coupled 5-HT1B/D receptor agonist sumatriptan induces type I hyperalgesic priming.Pain. 2016 Aug;157(8):1773-1782. doi: 10.1097/j.pain.0000000000000581. Pain. 2016. PMID: 27075428 Free PMC article.
-
Slow temporal summation of pain for assessment of central pain sensitivity and clinical pain of fibromyalgia patients.PLoS One. 2014 Feb 18;9(2):e89086. doi: 10.1371/journal.pone.0089086. eCollection 2014. PLoS One. 2014. PMID: 24558475 Free PMC article.
-
Interplay between noxious heat sensitivity and temporal summation magnitude in patients with fibromyalgia and long-term opioid use.Front Neurosci. 2023 Oct 12;17:1275921. doi: 10.3389/fnins.2023.1275921. eCollection 2023. Front Neurosci. 2023. PMID: 37901425 Free PMC article.
-
Chronic Opioid Therapy and Central Sensitization in Sickle Cell Disease.Am J Prev Med. 2016 Jul;51(1 Suppl 1):S69-77. doi: 10.1016/j.amepre.2016.02.012. Am J Prev Med. 2016. PMID: 27320469 Free PMC article.
-
[Altered pain thresholds during and after opioid withdrawal in patients with chronic low back pain].Schmerz. 2010 Jun;24(3):257-61. doi: 10.1007/s00482-010-0912-4. Schmerz. 2010. PMID: 20390305 German.
References
-
- Ali NM. Hyperalgesic response in a patient receiving high concentrations of spinal morphine. Anesthesiology. 1986;65:449. - PubMed
-
- Angst MS, Clark JD. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology. 2006;104:570–587. - PubMed
-
- Angst MS, Koppert W, Pahl I, Clark DJ, Schmelz M. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain. 2003;106:49–57. - PubMed
-
- Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003;349:1943–1953. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials